- NCT00231556
- Primary Citation Trial has yet to be published
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNervous System DiseasesEnrollment750% FemaleN/A% WhiteN/A
Product ClassAnticonvulsantsSponsor Protocol NumberTOPMAT-EPMN-106Data PartnerJohnson & JohnsonCondition StudiedEpilepsyMean/Median Age (Years)N/A
Supporting Documentation
- Protocol with Amendments Available
- Clinical Study Report Available
Additional Information
Please note: individual participant-level data are not available for this trial. Only the protocol with amendments and clinical study report are available.